Analgesics⏵
Antiandrogens⏵
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle⏵
Melatonin
Metformin
Minerals⏵
Molnupiravir
Monoclonals⏵
Naso/orophar..⏵
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins⏵
More⏵

Other
Feedback
Home
 
Top
..
Abstract
..
All quercetin studies
..
Meta analysis
..
Feedback
Home
←
next
study
→
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta
Home Adoption Other Treatments
@CovidAnalysis
All Studies   Meta Analysis       

In-silico Approach for Predicting the Inhibitory Effect of Home Remedies on Severe Acute Respiratory Syndrome Coronavirus-2

Thapa et al., Makara Journal of Science, doi:10.7454/mss.v27i3.1609
Sep 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
24th treatment shown to reduce risk in July 2021, now with p = 0.002 from 12 studies.
Lower risk for ICU, hospitalization, recovery, cases, and viral clearance.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
In Silico analysis showing that curcumin and quercetin may be beneficial for COVID-19 by binding to the main protease (Mpro), spike protein, and ACE2 receptor. Both compounds had suitable ADME properties and minimal predicted toxicity.
73 preclinical studies support the efficacy of quercetin for COVID-19:
45 In Silico studies1-45
22 In Vitro studies1,2,5,15,19,21,25,42,46-59
6 In Vivo animal studies5,19,52,55,60,61
In Silico studies predict inhibition of SARS-CoV-2, or minimization of side effects, with quercetin or metabolites via binding to the spikeA,3,9,10,22,24,25,30,38,39,41,42,62-64, MproB,3,7,9,11,13,15,17,18,20,23,24,30,34,36-38,42,43,45,63-65, RNA-dependent RNA polymeraseC,1,3,9,32,64, PLproD,3,37,45, ACE2E,22,23,28,37,41,63, TMPRSS2F,22, nucleocapsidG,3, helicaseH,3,29,34, endoribonucleaseI,39, NSP16/10J,6, cathepsin LK,26, Wnt-3L,22, FZDM,22, LRP6N,22, ezrinO,40, ADRPP,38, NRP1Q,41, EP300R,16, PTGS2S,23, HSP90AA1T,16,23, matrix metalloproteinase 9U,31, IL-6V,21,35, IL-10W,21, VEGFAX,35, and RELAY,35 proteins. In Vitro studies demonstrate inhibition of the MproB,15,46,51,59 protein, and inhibition of spike-ACE2 interactionZ,47. In Vitro studies demonstrate efficacy in Calu-3AA,50, A549AB,21, HEK293-ACE2+AC,58, Huh-7AD,25, Caco-2AE,49, Vero E6AF,19,42,49, mTECAG,52, and RAW264.7AH,52 cells. Animal studies demonstrate efficacy in K18-hACE2 miceAI,55, db/db miceAJ,52,61, BALB/c miceAK,60, and rats66. Quercetin reduced proinflammatory cytokines and protected lung and kidney tissue against LPS-induced damage in mice60, inhibits LPS-induced cytokine storm by modulating key inflammatory and antioxidant pathways in macrophages5, and inhibits SARS-CoV-2 ORF3a ion channel activity, which contributes to viral pathogenicity and cytotoxicity54.
Important missing comments or errors? Let us know.
Study covers curcumin and quercetin.
a. The trimeric spike (S) protein is a glycoprotein that mediates viral entry by binding to the host ACE2 receptor, is critical for SARS-CoV-2's ability to infect host cells, and is a target of neutralizing antibodies. Inhibition of the spike protein prevents viral attachment, halting infection at the earliest stage.
b. The main protease or Mpro, also known as 3CLpro or nsp5, is a cysteine protease that cleaves viral polyproteins into functional units needed for replication. Inhibiting Mpro disrupts the SARS-CoV-2 lifecycle within the host cell, preventing the creation of new copies.
c. RNA-dependent RNA polymerase (RdRp), also called nsp12, is the core enzyme of the viral replicase-transcriptase complex that copies the positive-sense viral RNA genome into negative-sense templates for progeny RNA synthesis. Inhibiting RdRp blocks viral genome replication and transcription.
d. The papain-like protease (PLpro) has multiple functions including cleaving viral polyproteins and suppressing the host immune response by deubiquitination and deISGylation of host proteins. Inhibiting PLpro may block viral replication and help restore normal immune responses.
e. The angiotensin converting enzyme 2 (ACE2) protein is a host cell transmembrane protein that serves as the cellular receptor for the SARS-CoV-2 spike protein. ACE2 is expressed on many cell types, including epithelial cells in the lungs, and allows the virus to enter and infect host cells. Inhibition may affect ACE2's physiological function in blood pressure control.
f. Transmembrane protease serine 2 (TMPRSS2) is a host cell protease that primes the spike protein, facilitating cellular entry. TMPRSS2 activity helps enable cleavage of the spike protein required for membrane fusion and virus entry. Inhibition may especially protect respiratory epithelial cells, buy may have physiological effects.
g. The nucleocapsid (N) protein binds and encapsulates the viral genome by coating the viral RNA. N enables formation and release of infectious virions and plays additional roles in viral replication and pathogenesis. N is also an immunodominant antigen used in diagnostic assays.
h. The helicase, or nsp13, protein unwinds the double-stranded viral RNA, a crucial step in replication and transcription. Inhibition may prevent viral genome replication and the creation of new virus components.
i. The endoribonuclease, also known as NendoU or nsp15, cleaves specific sequences in viral RNA which may help the virus evade detection by the host immune system. Inhibition may hinder the virus's ability to mask itself from the immune system, facilitating a stronger immune response.
j. The NSP16/10 complex consists of non-structural proteins 16 and 10, forming a 2'-O-methyltransferase that modifies the viral RNA cap structure. This modification helps the virus evade host immune detection by mimicking host mRNA, making NSP16/10 a promising antiviral target.
k. Cathepsin L is a host lysosomal cysteine protease that can prime the spike protein through an alternative pathway when TMPRSS2 is unavailable. Dual targeting of cathepsin L and TMPRSS2 may maximize disruption of alternative pathways for virus entry.
l. Wingless-related integration site (Wnt) ligand 3 is a host signaling molecule that activates the Wnt signaling pathway, which is important in development, cell growth, and tissue repair. Some studies suggest that SARS-CoV-2 infection may interfere with the Wnt signaling pathway, and that Wnt3a is involved in SARS-CoV-2 entry.
m. The frizzled (FZD) receptor is a host transmembrane receptor that binds Wnt ligands, initiating the Wnt signaling cascade. FZD serves as a co-receptor, along with ACE2, in some proposed mechanisms of SARS-CoV-2 infection. The virus may take advantage of this pathway as an alternative entry route.
n. Low-density lipoprotein receptor-related protein 6 is a cell surface co-receptor essential for Wnt signaling. LRP6 acts in tandem with FZD for signal transduction and has been discussed as a potential co-receptor for SARS-CoV-2 entry.
o. The ezrin protein links the cell membrane to the cytoskeleton (the cell's internal support structure) and plays a role in cell shape, movement, adhesion, and signaling. Drugs that occupy the same spot on ezrin where the viral spike protein would bind may hindering viral attachment, and drug binding could further stabilize ezrin, strengthening its potential natural capacity to impede viral fusion and entry.
p. The Adipocyte Differentiation-Related Protein (ADRP, also known as Perilipin 2 or PLIN2) is a lipid droplet protein regulating the storage and breakdown of fats in cells. SARS-CoV-2 may hijack the lipid handling machinery of host cells and ADRP may play a role in this process. Disrupting ADRP's interaction with the virus may hinder the virus's ability to use lipids for replication and assembly.
q. Neuropilin-1 (NRP1) is a cell surface receptor with roles in blood vessel development, nerve cell guidance, and immune responses. NRP1 may function as a co-receptor for SARS-CoV-2, facilitating viral entry into cells. Blocking NRP1 may disrupt an alternative route of viral entry.
r. EP300 (E1A Binding Protein P300) is a transcriptional coactivator involved in several cellular processes, including growth, differentiation, and apoptosis, through its acetyltransferase activity that modifies histones and non-histone proteins. EP300 facilitates viral entry into cells and upregulates inflammatory cytokine production.
s. Prostaglandin G/H synthase 2 (PTGS2, also known as COX-2) is an enzyme crucial for the production of inflammatory molecules called prostaglandins. PTGS2 plays a role in the inflammatory response that can become severe in COVID-19 and inhibitors (like some NSAIDs) may have benefits in dampening harmful inflammation, but note that prostaglandins have diverse physiological functions.
t. Heat Shock Protein 90 Alpha Family Class A Member 1 (HSP90AA1) is a chaperone protein that helps other proteins fold correctly and maintains their stability. HSP90AA1 plays roles in cell signaling, survival, and immune responses. HSP90AA1 may interact with numerous viral proteins, but note that it has diverse physiological functions.
u. Matrix metalloproteinase 9 (MMP9), also called gelatinase B, is a zinc-dependent enzyme that breaks down collagen and other components of the extracellular matrix. MMP9 levels increase in severe COVID-19. Overactive MMP9 can damage lung tissue and worsen inflammation. Inhibition of MMP9 may prevent excessive tissue damage and help regulate the inflammatory response.
v. The interleukin-6 (IL-6) pro-inflammatory cytokine (signaling molecule) has a complex role in the immune response and may trigger and perpetuate inflammation. Elevated IL-6 levels are associated with severe COVID-19 cases and cytokine storm. Anti-IL-6 therapies may be beneficial in reducing excessive inflammation in severe COVID-19 cases.
w. The interleukin-10 (IL-10) anti-inflammatory cytokine helps regulate and dampen immune responses, preventing excessive inflammation. IL-10 levels can also be elevated in severe COVID-19. IL-10 could either help control harmful inflammation or potentially contribute to immune suppression.
x. Vascular Endothelial Growth Factor A (VEGFA) promotes the growth of new blood vessels (angiogenesis) and has roles in inflammation and immune responses. VEGFA may contribute to blood vessel leakiness and excessive inflammation associated with severe COVID-19.
y. RELA is a transcription factor subunit of NF-kB and is a key regulator of inflammation, driving pro-inflammatory gene expression. SARS-CoV-2 may hijack and modulate NF-kB pathways.
z. The interaction between the SARS-CoV-2 spike protein and the human ACE2 receptor is a primary method of viral entry, inhibiting this interaction can prevent the virus from attaching to and entering host cells, halting infection at an early stage.
aa. Calu-3 is a human lung adenocarcinoma cell line with moderate ACE2 and TMPRSS2 expression and SARS-CoV-2 susceptibility. It provides a model of the human respiratory epithelium, but many not be ideal for modeling early stages of infection due to the moderate expression levels of ACE2 and TMPRSS2.
ab. A549 is a human lung carcinoma cell line with low ACE2 expression and SARS-CoV-2 susceptibility. Viral entry/replication can be studied but the cells may not replicate all aspects of lung infection.
ac. HEK293-ACE2+ is a human embryonic kidney cell line engineered for high ACE2 expression and SARS-CoV-2 susceptibility.
ad. Huh-7 cells were derived from a liver tumor (hepatoma).
ae. Caco-2 cells come from a colorectal adenocarcinoma (cancer). They are valued for their ability to form a polarized cell layer with properties similar to the intestinal lining.
af. Vero E6 is an African green monkey kidney cell line with low/no ACE2 expression and high SARS-CoV-2 susceptibility. The cell line is easy to maintain and supports robust viral replication, however the monkey origin may not accurately represent human responses.
ag. mTEC is a mouse tubular epithelial cell line.
ah. RAW264.7 is a mouse macrophage cell line.
ai. A mouse model expressing the human ACE2 receptor under the control of the K18 promoter.
aj. A mouse model of obesity and severe insulin resistance leading to type 2 diabetes due to a mutation in the leptin receptor gene that impairs satiety signaling.
ak. A mouse model commonly used in infectious disease and cancer research due to higher immune response and susceptibility to infection.
Thapa et al., 19 Sep 2023, peer-reviewed, 4 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
This PaperQuercetinAll
In-silico Approach for Predicting the Inhibitory Effect of Home In-silico Approach for Predicting the Inhibitory Effect of Home Remedies on Severe Acute Respiratory Syndrome Coronavirus-2 Remedies on Severe Acute Respiratory Syndrome Coronavirus-2
Shankar Thapa, Mahalakshmi Suresha Biradar, Janmajoy Banerjee, Dipanjan Karati
doi:10.7454/mss.v27i3.1609
Severe Acute Respiratory Syndrome Coronavirus-2 is an infectious disease caused by coronavirus and spreads through infected droplets inhalation. For the past 3 years, COVID-19 has become a global threat. Vaccinations are currently available and have FDA approval. During the recent pandemic, people adopted a psychological belief that home remedies (turmeric, ginger, garlic, and coriander) can prevent COVID-19. This research aimed to predict the covid-19 inhibitory activities by home remedies through an in-silico approach. The 24 bioactive constituents of four home remedies plants were
References
Ali, Kasry, Amin, The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant, Med. Drug Discov, doi:10.1016/j.medidd.2021.100086
Alkhamees, Alrashed, Alzunaydi, Almohimeed, Aljohani, The psychological impact of COVID-19 pandemic on the general population of Saudi Arabia, Compr. Psychiatry, doi:10.1016/j.comppsych.2020.152192
Barati, Pouresmaieli, Ekrami, Asghari, Ziarani et al., Potential drugs and remedies for the treatment of COVID-19: a Critical review, Biol. Proced. Online, doi:10.1186/s12575-020-00129-1
Barretto, Jukneliene, Ratia, Chen, Mesecar et al., The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity, J. Virol, doi:10.1128/JVI.79.24.15189-15198.2005
Beigel, Tomashek, Dodd, Mehta, Zingman et al., Remdesivir for the Treatment of Covid-19-Final Report, N. Engl. J. Med, doi:10.1056/NEJMoa2007764
Bhokardankar, Rathi, Khan, Rathi, COVID-19 pandemic: Home remedies for immunity boosting, Int. J. Res. Pharm. Sci
Boopathi, Poma, Kolandaivel, Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment, J. Biomol. Struct. Dyn, doi:10.1080/07391102.2020.1758788
Chan, Dorosky, Sharma, Abbasi, Dye et al., Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2, Science, doi:10.1126/science.abc0870
Ciotti, Ciccozzi, Terrinoni, Jiang, Wang et al., The COVID-19 pandemic, Crit. Rev. Clin. Lab. Sci, doi:10.1080/10408363.2020.1783198
Dousari, Moghadam, Satarzadeh, COVID-19 (Coronavirus disease 2019): A New coronavirus disease, Infect. Drug Resist, doi:10.2147/IDR.S259279
Drwal, Banerjee, Dunkel, Wettig, Preissner, ProTox: A web server for the in silico prediction of rodent oral toxicity, Nucleic. Acids Res, doi:10.1093/nar/gku401
Ekins, Mottin, Ramos, Sousa, Neves et al., Stimulating open drug discovery for SARS-CoV-2, Drug Discov. Today, doi:10.1016/j.drudis.2020.03.019
Fan, Fu, Zhang, Progress in molecular docking, Quant. Biol
Filimonov, Lagunin, Gloriozova, Rudik, Druzhilovskii et al., prediction of the biological activity spectra of organic compounds using the pass online web resource, Chem. Heterocycl. Compd, doi:10.1007/s10593-014-1496-1
Ghosh, Tripathi, Talukdar, Talaptara, In silico study by using ProTox-II webserver for oral acute toxicity, organ toxicity, immunotoxicity, genetic toxicity endpoints, nuclear receptor signalling and stress response pathways of synthetic pyrethroids, World Sci. News
Gupta, Pharmacological properties and traditional therapeutic uses of important Indian spices: A Review, Int. J. Food Prop, doi:10.1080/10942910902963271
Islam, Ferdousi, Shahinozzaman, Previously published ethno-pharmacological reports reveal the potentiality of plants and plantderived products used as traditional home remedies by Bangladeshi COVID-19 patients to combat SARS-CoV-2, Saudi J. Biol. Sci, doi:10.1016/j.sjbs.2021.07.036
Jafarzadeh, Jafarzadeh, Nemati, Therapeutic potential of ginger against COVID-19: Is there enough evidence?, J. Tradit. Chinese Med. Sci
Jin, Du, Xu, Deng, Liu et al., Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors, Nature, doi:10.1038/s41586-020-2223-y
Joshi, Joshi, Sharma, Mathpal, Pundir et al., In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking, Eur. Rev. Med. Pharmacol. Sci, doi:10.26355/eurrev_202004_21036
Kannan, Spratt, Cohen, Naqvi, Chand et al., Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses, J. Autoimmun
Kumar, Doshi, Khan, Rathore, COVID-19 pandemic: mechanism, diagnosis, and treatment, J. Chem. Technol. Biotechnol, doi:10.1002/jctb.6641
Li, Moore, Vasilieva, Sui, Wong et al., Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, doi:10.1038/nature02145
Lipinski, Lombardo, Dominy, Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev
Luthra, Singh, Chandra, Therapeutic uses of curcuma longa (turmeric), Indian J. Clin. Biochem, doi:10.1007/BF02864854
Majeed, Hussain, Yasmin, Akhtar, Rasool, Virtual screening of phytochemicals by targeting HR1 domain of SARS-CoV-2 S protein: Molecular docking, molecular dynamics simulations, and DFT studies, Biomed. Res. Int, doi:10.1155/2021/6661191
Majumder, Mandal, Screening of plantbased natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach, J. Biomol. Struct. Dyn, doi:10.1080/07391102.2020.1817787
Moghadamtousi, Kadir, Hassandarvish, Tajik, Abubakar et al., A review on antibacterial, antiviral, and antifungal activity of curcumin, Biomed. Res. Int, doi:10.1155/2014/186864
Nag, Banerjee, Chowdhury, Venkatesh, Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study, VirusDisease, doi:10.1007/s13337-021-00654-x
Negi, Bala, Natural home remedies may act as potential immunomodulatore to protect against SARS-COV-2 infection, J. Exp. Biol. Agric. Sci, doi:10.18006/2020.8(Spl-1-SARS-CoV-2).S176.S189
Niranjan, Prakash, Chemical constituents and biological activities of turmeric (Curcuma longa L.)-A review, J. Food Sci. Technol
Nur, Azam, Al Mahamud, Hasan, Jahan et al., Some home remedies used In-silico Approach for Predicting the Inhibitory Effect 207, J Med Plants Stud
Orisakwe, Orish, Nwanaforo, Coronavirus disease (COVID-19) and Africa: Acclaimed home remedies, Sci. African, doi:10.1016/j.sciaf.2020.e00620
Pham, Nguyen, Tam, Vu, Pham et al., Improving Ligand-Ranking of AutoDock Vina by Changing the Empirical Parameters, J. Comput. Chem, doi:10.1002/jcc.26779
Pillaiyar, Manickam, Namasivayam, Hayashi, Jung, An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy, J. Med. Chem, doi:10.1021/acs.jmedchem.5b01461
Prati, Mancini, The psychological impact of COVID-19 pandemic lockdowns: a review and meta-analysis of longitudinal studies and natural experiments, Psychol. Med, doi:10.1017/S0033291721000015
Rabie, CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy, Mol. Divers, doi:10.1007/s11030-020-10169-0
Rathinavel, Palanisamy, Palanisamy, Subramanian, Thangaswamy, Phytochemical 6-Gingerol-A promising Drug of choice for COVID-19, Int. J. Adv. Sci. Eng, doi:10.29294/IJASE.6.4.2020.1482-1489
Rothan, Byrareddy, The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak, J. Autoimmun, doi:10.1016/j.jaut.2020.102433
Rouf, Uddin, Sarker, Islam, Ali et al., Antiviral potential of garlic (Allium sativum) and its organosulfur compounds: A systematic update of pre-clinical and clinical data, Trends Food Sci. Technol, doi:10.1016/j.tifs.2020.08.006
Roy, Singh, Mishra, Chinnadurai, Mitra et al., Mental health implications of COVID-19 pandemic and its response in India, Int. J. Soc. Psychiatry
Seeliger, De Groot, Ligand docking and binding site analysis with PyMOL and Autodock/Vina, J. Comput. Aided Mol. Des, doi:10.1007/s10822-010-9352-6
Semwal, Chauhan, Kumar, Aswal, Semwal et al., Status of Indian medicinal plants in the international union for conservation of nature and the future of Ayurvedic drugs: Shouldn't think about Ayurvedic fundamentals?, J. Integr. Med, doi:10.1016/j.joim.2019.04.008
Shaker, Yu, Lee, Lee, Jung et al., User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation, J. Microbiol, doi:10.1007/s12275-020-9563-z
Singh, Chauhan, Pandit, Sinha, Gupta et al., The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins, J. Tradit. Complem. Med, doi:10.1016/j.jtcme.2021.09.001
Singh, Kumar, Jyoti, Kumar, Spices and herbs: Potential antiviral preventives and immunity boosters during COVID-19, Phyther. Res, doi:10.1002/ptr.7019
Singletary, Coriander: Overview of potential health benefits, Nutr. Today, doi:10.1097/NT.0000000000000159
Tesfaye, Mengesha, traditional uses , phytochemistry and pharmacological properties of garlic (Allium sativum) and its biological active compounds, Int. J. Sci. Res. Sci. Eng. Technol
Thapa, Nargund, Biradar, Banerjee, Karati, In-silico investigation and drug likeliness studies of benzimidazole congeners: The new face of innovation, Inform. Med. Unlocked
Thapa, Nargund, Biradar, Molecular design and In-Silico analysis of trisubstituted benzimidazole derivatives as ftsz inhibitor, J. Chem, doi:10.1155/2023/9307613
Thapa, Nargund, Biradar, Yadav, Mishra, A Respiratory review on Covid-19: Pathophysiology, diagnosis, treatment, and prevention, J. Biomed. Pharm. Res
Thapa, None, J. Sci
Towler, Staker, Prasad, Menon, Tang et al., ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis, J. Biol. Chem, doi:10.1074/jbc.M311191200
Trott, Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem
Umashankar, Deshpande, Hegde, Singh, Chattopadhyay, Phytochemical moieties from Indian traditional medicine for targeting dual hotspots on SARS-CoV-2 spike protein: An Integrative in-silico approach, Front. Med, doi:10.3389/fmed.2021.672629
Xiong, Wu, Yi, Fu, Yang et al., ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties, Nucleic. Acids Res, doi:10.1093/nar/gkab255
Zarei, Ramazani, Pourmand, Sattari, Rezaei et al., In silico evaluation of COVID-19 main protease interactions with honeybee natural products for discovery of high potential antiviral compounds, Nat. Prod. Res, doi:10.1080/14786419.2021.1974435
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0